The ninth annual meeting of the Society of Hematologic Oncology will be held as a virtual event on September 8-11, 2021. The in-person portion of the meeting has been cancelled due to rising Covid rates in the Houston area. In-person registrations will automatically be transferred to virtual registrations with a partial refund. Delegates may continue to register for the virtual meeting.

The SOHO annual meeting program will focus on cutting-edge advances and practical clinical applications, with special emphasis on novel biological and therapeutic approaches, for patients with hematologic malignancies. In addition, the speakers are a multidisciplinary group of internationally recognized experts that represent the spectrum of these diseases.

 TARGETED AUDIENCE

This accredited CE activity is directed towards physicians, fellows, nurses, physician assistants, pharmacists, and students interested in Hematology Oncology, Medical Oncology and Internal Medicine.

EDUCATIONAL OBJECTIVES

After completing this accredited CE activity, the participant should be better able to:

• Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of hematologic malignancies.
• Debate the benefits of maintenance therapies in patients with hematologic malignancies while integrating key findings into clinical practice to improve patient care.
• Describe the clinical and molecular facets of biology, pathogenesis, diagnostic approaches and therapeutic modalities available for various hematologic disorders.
• Apply novel interprofessional team-based treatment strategies for patients with hematologic malignancies while evaluating the practical utility of novel agents based on data from recent clinical studies to improve outcomes.
• Differentiate the evolving therapeutic strategies for first-line, second-line, third-line, and salvage treatment of hematologic malignancies in order to apply these strategies into practice.

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and the Society for Hematologic Oncology (SOHO). Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 30.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.